Shusted Christine S, Mukhtar Sarah, Lee James, Ruane Brooke, Muse Emily, Emeigh-McBride Lawrence, Gatson-Anderson Eboni, Kane Gregory C, Wen Kuang-Yi, Juon Hee-Soon, Barta Julie A
The Jane and Leonard Korman Respiratory Institute, Division of Pulmonary and Critical Care Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
Cancer Control. 2024 Jan-Dec;31:10732748241304966. doi: 10.1177/10732748241304966.
Optimal approaches for tobacco treatment counseling among individuals who currently smoke and are undergoing shared decision-making (SDM) and lung cancer screening (LCS) are unknown. The objective of this cross-sectional study was to determine the rate of reported interest in tobacco treatment counseling and pharmacotherapy among individuals who currently smoke and are receiving integrated nurse navigation for LCS and tobacco treatment in a centralized LCS Program.
We identified individuals undergoing SDM through our centralized LCS Program between March 2021 and March 2022. The LCS Program tobacco treatment protocol includes counseling both in-person and via telephone during SDM, LCS results review, and an optional 4-week follow-up. Sociodemographic and clinical data for currently smoking individuals participating in LCS were extracted from the LCS Registry.
Among 1034 individuals undergoing LCS through the centralized program, 605 were currently smoking and comprised the study cohort. Nearly half (49.8%) reported interest in tobacco treatment counseling and pharmacotherapy and received a personalized treatment plan. On multivariate analysis, factors significantly associated with expressing interest in treatment included African-American/Black race, higher educational attainment, and returning visit type. Among the 301 individuals expressing interest in tobacco treatment, 35 (11.6%) had documentation of self-reported smoking cessation in the electronic health record. Successful smoking cessation for any length of time was significantly associated with receiving at least one longitudinal tobacco cessation counseling telephone call.
In a centralized LCS Program offering tobacco treatment integrated with screening services, race, education, and visit type were significantly associated with expressing interest in tobacco treatment counseling and pharmacotherapy, while longitudinal tobacco counseling telephone calls were associated with smoking cessation. Randomized controlled trials are needed to test whether this integrated strategy leads to LCS- and tobacco-related outcomes.
对于目前正在吸烟且正在进行共同决策(SDM)和肺癌筛查(LCS)的个体,最佳的烟草治疗咨询方法尚不清楚。这项横断面研究的目的是确定在一个集中的LCS项目中,目前正在吸烟且正在接受LCS和烟草治疗综合护士导航的个体中,报告对烟草治疗咨询和药物治疗感兴趣的比例。
我们确定了2021年3月至2022年3月期间通过我们的集中LCS项目进行共同决策的个体。LCS项目的烟草治疗方案包括在共同决策、LCS结果审查期间进行面对面和电话咨询,以及一次可选的4周随访。从LCS登记处提取参与LCS的目前吸烟个体的社会人口学和临床数据。
在通过该集中项目接受LCS的1034名个体中,605名目前正在吸烟,构成了研究队列。近一半(49.8%)报告对烟草治疗咨询和药物治疗感兴趣,并接受了个性化治疗计划。在多变量分析中,与表达治疗兴趣显著相关的因素包括非裔美国人/黑人种族、较高的教育程度和回访类型。在301名对烟草治疗感兴趣的个体中,35名(11.6%)在电子健康记录中有自我报告戒烟的记录。任何时长的成功戒烟都与至少接受一次纵向烟草戒烟咨询电话显著相关。
在一个提供与筛查服务相结合的烟草治疗的集中LCS项目中,种族、教育程度和回访类型与对烟草治疗咨询和药物治疗的兴趣表达显著相关,而纵向烟草咨询电话与戒烟相关。需要进行随机对照试验来测试这种综合策略是否能带来与LCS和烟草相关的结果。